Surprising Analyst 12-Month Target For TACK

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA Markets TACK Surprising Analyst 12-Month Target For TACK March 19, 2026 — 06:50 am EDT Written by BNK Invest for BNK Invest-> Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Fairlead Tactical Sector ETF (Symbol: TACK), we found that the implied analyst target price for the ETF based upon its underlying holdings is $34.06 per unit. With TACK trading at a recent price near $30.57 per unit, that means that analysts see 11.43% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of TACK's underlying holdings with notable upside to their analyst target prices are Select Sector SPDR Trust - State Street Health Care Select Sector SPDR ETF (Symbol: XLV), Select Sector SPDR Trust - State Street Industrial Select Sector SPDR ETF (Symbol: XLI), and Select Sector SPDR Trust - State Street Materials Select Sector SPDR ETF (Symbol: XLB). Although XLV has traded at a recent price of $147.14/share, the average analyst target is 14.31% higher at $0.00/share. Similarly, XLI has 12.66% upside from the recent share price of $165.18 if the average analyst target price of $0.00/share is reached, and analysts on average are expecting XLB to reach a target price of $0.00/share, which is 11.64% above the recent price of $48.48. Below is a twelve month price history chart comparing the stock performance of XLV, XLI, and XLB: Combined, XLV, XLI, and XLB represent 36.19% of the Fairlead Tactical Sector ETF. Below is a summary table of the current analyst target prices discussed above: Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target Fairlead Tactical Sector ETF TACK $30.57 $34.06 11.43% Select Sector SPDR Trust - State Street Health Care Select Sector SPDR ETF XLV $147.14 $0.00 14.31% Select Sector SPDR Trust - State Street Industrial Select Sector SPDR ETF XLI $165.18 $0.00 12.66% Select Sector SPDR Trust - State Street Materials Select Sector SPDR ETF XLB $48.48 $0.00 11.64%Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research. 10 ETFs With Most Upside To Analyst Targets » Also see: • REITs Hedge Funds Are Selling • SINO shares outstanding history • Preferred Stocks By Industry The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Tags MarketsStocksETFs BNK Invest BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally. REITs Hedge Funds Are Selling-> SINO shares outstanding history-> Preferred Stocks By Industry-> More articles by this source-> Stocks mentioned TACK XLV XLI XLB More Related Articles This data feed is not available at this time. Data is currently not available • Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.